Skip to content

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial - WSJ - LyscoNews | LyscoNews

Top Stories Sources Pricing History Settings

Top Stories/world

WORLDglobal

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial - WSJ

Single source

Updated 2 hours ago

First seen March 23, 2026 16:27:33

Stay on top of this story

Follow the names and topics behind it.

Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.

Create free account

Create a free account to sync your watchlist, saved stories, and alerts across devices.

Quick Summary

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial WSJ

Deeper Analysis

Make this useful tomorrow too

Create a free account.

Save stories, keep your follows, and get pulled back in when this topic moves again.

Create free account See Premium

Source mix

Avg. source credibility: 90%

Regional / Local (1)

Wall Street Journal90%

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial - WSJ

Only covered by regional / local sources

Team notes

All coverage links (1)

Wall Street JournalRegional / Local

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial - WSJ

Perspective lens

Team Notes

Share with team